Research Article
Value of 18F-FDG PET/CT Combined with Lung HRCT in Diagnosis of Solitary Pulmonary Intravascular Metastasis
Table 1
Demographic, clinical data, and imaging data of 13 patients with pulmonary tumor thrombosis.
| Patient no. | Age (y) | Sex | Primary tumor | Respiratory symptoms | Metastasis no. | Location | SUVmax | Length (mm) | Pulmonary vascular morphology | Follow-up |
| 1 | 58 | F | Lung | None | 1 | RUL | 1.1 | 5.2 | Normal | Lymphatic metastasis | 2 | 57 | M | Lung | Cough | 1 | LLL | 3.2 | 11.8 | Thickening | Tumor recurrence and organ metastasis | 3 | 53 | M | Lung | None | 1 | RUL | 2.7 | 24.1 | Thickening | No tumor recurrence or new metastasis | 4 | 57 | F | Cervical | None | 2 | RUL/LUL | 5.4/4.3 | 22.7/23.7 | Thickening | Tumor recurrence | 5 | 45 | F | Cervical | None | 1 | RUL | 1.2 | 6.2 | Thickening | Lymphatic metastasis | 6 | 30 | F | Cervical | None | 2 | RUL/RUL | 1.5/1.2 | 5.1/7.4 | Thickening | No tumor recurrence or new metastasis | 7 | 45 | F | Rectal | None | 1 | LLL | 1.9 | 9.8 | Thickening | Lymphatic metastasis | 8 | 38 | F | Breast | None | 1 | RML | 1.3 | 8.2 | Thickening | Organ metastasis | 9 | 74 | M | Esophageal | Asthma | 2 | RUL/LLL | 3.0/2.0 | 9.9/7.1 | Thickening | Lymphatic metastasis and organ metastasis | 10 | 59 | M | Esophageal | None | 1 | LUL | 1.1 | 6.2 | Normal | Tumor recurrence and lymphatic metastasis | 11 | 60 | F | Gastric | None | 1 | LUL | 3.8 | 13.2 | Thickening | Lymphatic metastasis | 12 | 59 | M | Pancreatic | None | 2 | RUL/RUL | 1.1/1.3 | 5.2/6.6 | Thickening | Organ metastasis | 13 | 59 | F | Pancreatic | None | 1 | RLL | 4.1 | 9.1 | Thickening | Tumor recurrence and lymphatic metastasis |
|
|
F, female; M, male; RUL, right upper lobe; RML, right middle lobe; RLL, right lower lobe; LUL, left upper lobe; LLL, left lower lobe.
|